Maurer et al. The international WAO/EAACI guideline for the management of hereditary angioedema, The 2021 revision and update; Allergy. 2022;77:1961–1990
Bork et al. Assessment and management of disease burden and quality of life in patients with hereditary angioedema: a consensus report; Allergy Asthma Clin Immunol. 2021; 17:40
Bork et al. Hereditary Angioedema: New findings Concerning Symptoms, Affected Organs, and Course; The American Journal of Medicine 2006; 118, 267-274
Azmy et al. Clinical presentation of hereditary angioedema. Allergy Asthma Proc.2020:41:S18–S21
Bernstein J.A. Severity of Hereditary Angioedema, Prevalence, and Diagnostic Considerations; AJMC 2018
Mendivil et al. Clinical characteristics and burden of illness in patients with hereditary angioedema: findings from a multinational patient survey; Orphanet J Rare Dis 2021:16:94
Zanichelli et al. Misdiagnosis trends in patients with hereditary angioedema from the real-world clinical setting; Allergy Asthma Immunol 2016: 117, 394-398
Bork et al. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency: J Allergy Clin Immunol. 2012; 130:3
Farkas H. Management of upper airway edema caused by hereditary angioedema: Allergy, Asthma & Clinical Immunology 2010; 6:19
Magerl M. et al. Characterization of prodromal symptoms in a large population of patients with hereditary angio-oedema: Clinical and Experimental Dermatology 2014; 39, 298-303
Zuraw B.L. Hereditary Angioedema: N Engl J Med. 2008; 359:1027-36
Zotter Z. et al. The influence of trigger factors on hereditary angioedema due to C1-inhibitor deficiency. Orphanet Journal of Rare Diseases 2014: 9:44
Maurer et al. Consensus on treatment goals in hereditary angioedema: A global Delphi initiative. J Allergy Clin Immunol 2021; 148:6
Elwyn G. et al. Shared Decision Making: A Model for Clinical Practice. J Gen Intern Med 2012; 27(10):1361–7
Busse P.J. et al. US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema. J Allergy Clin Immunol Pract 2021;9:132-50
Caballero T. et al. International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency. American Academy of Allergy, Asthma & Immunology 2012; 129:2
Johnston D.T. et al. Hereditary angioedema: special considerations in children. Allergy and Asthma Proc 2020; 41:S43–S46
Aygoren-Pursun E. et al. Socioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in Europe. Orphanet Journal of Rare Diseases 2014; 9:99
Lumry & Settipane. Hereditary angioedema: Epidemiology and burden of disease. Allergy Asthma Proc 2020; 41:S8–S13
Banerji A. & Riedl M. Managing the female patient with hereditary angioedema. Womens Health 2016; 12 (3 ), 351–361
Bouillet L. et al. Disease expression in women with hereditary angioedema. Am J Obstet Gynecol 2008;199:484.e1-484.e4
Hsu F.I. et al. Considerations in the management of hereditary angioedema due to C1‑INH deficiency in women of childbearing age. Allergy, Asthma & Clinical Immunology 2022; 18:64
Betschzel et all. The International/Canadian Hereditary Angioedema Guideline Allergy, Asthma & Clinical Immunology 2019; 15:72
Henri Li et al. Update on the Use of C1-Esterase Inhibitor Replacement Therapy in the Acute and Prophylactic Treatment of Hereditary Angioedema. Clinical Reviews in Allergy & Immunology 2019; 56:207–218
